Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Cardiology-CTVS
  • Cardiology & CTVS News
  • ABYSS Trial Finds...

ABYSS Trial Finds Elevated BP, HR & Deleterious CV Outcomes After Beta blocker Withdrawal Post-MI: EuroPCR 2025 Update

Written By : Dr. Garima Soni Published On 2025-06-05T12:00:24+05:30  |  Updated On 5 Jun 2025 3:25 PM IST
ABYSS Trial Finds Elevated BP, HR & Deleterious CV Outcomes After Beta blocker Withdrawal Post-MI: EuroPCR 2025 Update
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Discontinuing Beta-blocker therapy after an uncomplicated myocardial infarction (MI) was found to cause a persistent rise in blood pressure (BP) and heart rate (HR), with potentially harmful effects on clinical outcomes, particularly in patients with a history of hypertension, as highlighted by the ABYSS trial.

The study was published in the May 2025 Issue of the European Heart Journal, and also presented at the EuroPCR 2025 Conference held in Paris, France

The role of β-blockers in stable, revascularized patients with uncomplicated myocardial infarction and preserved left ventricular ejection fraction (LVEF) remains uncertain. Recent guidelines suggest discontinuing them after the acute phase if there is no heart failure or left ventricular (LV) dysfunction, though their effect on heart rate (HR) and blood pressure (BP) as key prognostic factors in coronary artery disease keeps their use relevant. The European Society of Hypertension and the European Society of Cardiology recommend β-blockers for hypertension only when specific conditions like heart failure with reduced ejection fraction (HFrEF), chronic coronary syndromes, or atrial fibrillation are present.

Given this uncertainty, AβYSS trial was conducted, which is a multicentre, randomized, open-label, non-inferiority trial, to evaluate the impact of β-blocker interruption on blood pressure (BP) and heart rate (HR) in patients with a prior myocardial infarction and preserved LVEF.

A total of 3,698 patients at least six months post-myocardial infarction, on β-blocker therapy, and without chronic heart failure or reduced LVEF (<40%) were enrolled and randomized to either continue (n=1,852) or discontinue (n=1,846) β-blockers. Changes in heart rate and blood pressure from baseline were analyzed using a linear mixed repeated model over a median follow-up of 3 years. The study also assessed these changes and their association with the primary endpoint (death, MI, stroke, hospitalization for cardiovascular reason) in subgroups with or without a history of hypertension using linear mixed repeated and adjusted Cox proportional hazards models.

The key results from the study include:

  1. Impact of β-blocker interruption or continuation on haemodynamics in the randomized groups: At 6 months, patients in the β-blocker interruption group showed a significant increase in resting heart rate (+9.8 bpm, P < .001), systolic BP (+3.7 mmHg, P < .001) and diastolic BP (+3.3 mmHg, P < .001), compared to the continuation group (all P < .001). These effects remained stable over time, despite more frequent use and dose escalation of other antihypertensive drugs in the interruption group (10.8% vs 4.0%).
  1. Comparison of patients with a prior history of hypertension vs. no prior hypertension: The haemodynamic impact of β-blocker interruption was consistent across patients with or without a history of hypertension. However, hypertensive patients had a higher incidence of the primary outcome [25.8% vs 19.2%; adjusted HR (Hazard Ratio) 1.18, P = .03], identifying them as a higher-risk group. The harm from β-blocker interruption appeared more pronounced in hypertensive patients [risk difference 5.02%, adjusted HR 1.23, P = .04], primarily driven by increased hospitalizations for cardiovascular causes, including coronary events, heart failure, and supraventricular tachycardia. Despite this, the overall effect of interruption was consistent across both subgroups (interaction P = .26).

The findings suggest that interrupting β-blockers beyond 6 months in stable post-myocardial infarction patients leads to a sustained increase in systolic and diastolic blood pressure and heart rate, posing potential long-term risks, especially in those with a history of hypertension.

Reference: Niki Procopi, Michel Zeitouni, Mathieu Kerneis, Guillaume Cayla, Emile Ferrari, Grégoire Range, Etienne Puymirat, Nicolas Delarche, Paul Guedeney, Farzin Beygui, Laurent Desprets, Jean-Louis Georges, Thomas Bochaton, François Schiele, Grégory Ducrocq, Marie Hauguel-Moreau, Raphaelle Dumaine, Michel S Slama, Laurent Payot, Mohamad El Kasty, Karim Aacha, Abdourahmane Diallo, Xavier Girerd, Eric Vicaut, Johanne Silvain, Gilles Montalescot, on behalf of the AβYSS Investigators of the ACTION Study Group, Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AβYSS trial, European Heart Journal, 2025;, ehaf170, https://doi.org/10.1093/eurheartj/ehaf170

AβYSS Trialβ-blockerEuropean Heart JournalEuroPCRblood pressuremetoprololhypertension
Source : European Heart Journal
Dr. Garima Soni
Dr. Garima Soni

    BDS, MDS(orthodontics)

    Dr. Garima Soni holds a BDS (Bachelor of Dental Surgery) from Government Dental College, Raipur, Chhattisgarh, and an MDS (Master of Dental Surgery) specializing in Orthodontics and Dentofacial Orthopedics from Maitri College of Dentistry and Research Centre. At medical dialogues she focuses on dental news and dental and medical fact checks against medical/dental mis/disinformation

    Show Full Article
    Next Story

    Editorial

    ABYSS Trial Finds Elevated BP, HR & Deleterious CV Outcomes After Beta blocker Withdrawal Post-MI: EuroPCR 2025 Update

    ABYSS Trial Finds Elevated BP, HR & Deleterious CV Outcomes After Beta blocker Withdrawal Post-MI:...

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    View All

    Journal Club Today

    Study Unveils Molecular Links between Air Pollution and Negative Birth Outcomes

    Study Unveils Molecular Links between Air Pollution and Negative Birth Outcomes

    View All

    Health News Today

    Health Bulletin 05/June/2025

    Health Bulletin 05/June/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok